LEXAGENE HOLDINGS INC (LXG.CA) Fundamental Analysis & Valuation

TSX-V:LXG • CA52886L1031

Current stock price

0.105 CAD
-0.03 (-19.23%)
Last:

This LXG.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. LXG.CA Profitability Analysis

1.1 Basic Checks

  • In the past year LXG has reported negative net income.
  • LXG had a negative operating cash flow in the past year.
LXG.CA Yearly Net Income VS EBIT VS OCF VS FCFLXG.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

  • The profitability ratios for LXG are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LXG.CA Yearly ROA, ROE, ROICLXG.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 200 -200 -400 -600

1.3 Margins

  • LXG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LXG.CA Yearly Profit, Operating, Gross MarginsLXG.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 -5K -10K -15K

1

2. LXG.CA Health Analysis

2.1 Basic Checks

  • LXG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • LXG has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, LXG has a worse debt to assets ratio.
LXG.CA Yearly Shares OutstandingLXG.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
LXG.CA Yearly Total Debt VS Total AssetsLXG.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -32.50, we must say that LXG is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -32.50, LXG is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
  • LXG has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.44, LXG is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z -32.5
ROIC/WACCN/A
WACC9.69%
LXG.CA Yearly LT Debt VS Equity VS FCFLXG.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M

2.3 Liquidity

  • LXG has a Current Ratio of 1.39. This is a normal value and indicates that LXG is financially healthy and should not expect problems in meeting its short term obligations.
  • LXG has a Current ratio of 1.39. This is in the lower half of the industry: LXG underperforms 60.00% of its industry peers.
  • LXG has a Quick Ratio of 1.39. This is a bad value and indicates that LXG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of LXG (0.51) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.51
LXG.CA Yearly Current Assets VS Current LiabilitesLXG.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

1

3. LXG.CA Growth Analysis

3.1 Past

  • The earnings per share for LXG have decreased strongly by -45.78% in the last year.
  • LXG shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.22%.
EPS 1Y (TTM)-45.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.52%
Revenue 1Y (TTM)32.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LXG.CA Yearly Revenue VS EstimatesLXG.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 500K 1M 1.5M 2M 2.5M
LXG.CA Yearly EPS VS EstimatesLXG.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 -0.05 -0.1

0

4. LXG.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • LXG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LXG.CA Price Earnings VS Forward Price EarningsLXG.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LXG.CA Per share dataLXG.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. LXG.CA Dividend Analysis

5.1 Amount

  • No dividends for LXG!.
Industry RankSector Rank
Dividend Yield N/A

LXG.CA Fundamentals: All Metrics, Ratios and Statistics

LEXAGENE HOLDINGS INC

TSX-V:LXG (2/21/2023, 7:00:00 PM)

0.105

-0.03 (-19.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.77M
Revenue(TTM)194.46K
Net Income(TTM)-16.51M
Analysts84.44
Price Target0.51 (385.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 55.84
P/FCF N/A
P/OCF N/A
P/B 8.53
P/tB 8.76
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.51
Altman-Z -32.5
F-Score3
WACC9.69%
ROIC/WACCN/A
Cap/Depr(3y)9.71%
Cap/Depr(5y)721.12%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.22%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.81%
OCF growth 3YN/A
OCF growth 5YN/A

LEXAGENE HOLDINGS INC / LXG.CA Fundamental Analysis FAQ

What is the fundamental rating for LXG stock?

ChartMill assigns a fundamental rating of 1 / 10 to LXG.CA.


What is the valuation status for LXG stock?

ChartMill assigns a valuation rating of 1 / 10 to LEXAGENE HOLDINGS INC (LXG.CA). This can be considered as Overvalued.


What is the profitability of LXG stock?

LEXAGENE HOLDINGS INC (LXG.CA) has a profitability rating of 1 / 10.